Atomo Diagnostics Ltd.ASX: AT1

Atomo Signs Agreement with Innovation Scientific

· Issued by Atomo Diagnostics Ltd. via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Innovation Scientific will handle the development and clinical studies, while Atomo will manufacture the product and seek regulatory approval. The agreement is considered strategically significant for Atomo, as it aims to expand its product portfolio and revenue streams in the HIV testing market. Atomo expects to launch the new product commercially within two years, enhancing its offerings in decentralized testing locations.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/atomo-signs-agreement-with-innovation-scientific-1

Release

th ASX Announcement 29 October 2026 Atomo Signs Agreement with Innovation Scientific to Develop a Generation 4 HIV Assay • In partnership with Innovation Scientific, Atomo formally launches a development program for Gen 4 HIV in its Galileo cassette • Innovation Scientific will complete the...

Atomo Diagnostics Ltd. on 6ix

In the deck

Earlier from Atomo Diagnostics

Later from Atomo Diagnostics

All Atomo Diagnostics news releases